Compounds > nafoxidine

nafoxidine and piperidines

nafoxidine has been researched along with piperidines in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's5 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bern, HA; Chou, YC; Iguchi, T1
Gottardis, MM; Jordan, VC; Satyaswaroop, PG1
Bryant, HU; Rippy, MK; Sato, M1
Logie, C; Nichols, M; Rientjes, JM; Stewart, AF1
Jeannin, E; Liu, JW; Picard, D1

Other Studies

5 other study(ies) available for nafoxidine and piperidines

ArticleYear
Effects of antiestrogens on adult and neonatal mouse reproductive organs.
    Reproductive toxicology (Elmsford, N.Y.), 1992, Volume: 6, Issue:5

    Topics: Animals; Animals, Newborn; Body Weight; Clomiphene; Estrogen Antagonists; Female; Genitalia, Female; Genitalia, Male; Male; Mice; Mice, Inbred C57BL; Nafoxidine; Organ Size; Ovariectomy; Ovary; Piperidines; Raloxifene Hydrochloride; Tamoxifen; Trifluoperazine; Uterus; Vagina

1992
Tamoxifen-stimulated growth of human endometrial carcinoma.
    Annals of the New York Academy of Sciences, 1991, Volume: 622

    Topics: Animals; Antineoplastic Agents; Cell Transformation, Neoplastic; Clomiphene; Enclomiphene; Endometrium; Estradiol; Estrogen Antagonists; Female; Humans; Mice; Mice, Inbred BALB C; Nafoxidine; Neoplasm Transplantation; Piperidines; Polyunsaturated Alkamides; Pyrrolidines; Raloxifene Hydrochloride; Receptors, Estrogen; Receptors, Progesterone; Tamoxifen; Uterine Neoplasms

1991
Raloxifene, tamoxifen, nafoxidine, or estrogen effects on reproductive and nonreproductive tissues in ovariectomized rats.
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology, 1996, Volume: 10, Issue:8

    Topics: Adipose Tissue; Animals; Bone Density; Estrogen Antagonists; Estrogens; Female; Lipid Metabolism; Nafoxidine; Ovariectomy; Piperidines; Raloxifene Hydrochloride; Rats; Rats, Sprague-Dawley; Reproduction; Tamoxifen; Uterus

1996
FLP recombinase/estrogen receptor fusion proteins require the receptor D domain for responsiveness to antagonists, but not agonists.
    Molecular endocrinology (Baltimore, Md.), 1997, Volume: 11, Issue:7

    Topics: Amino Acid Sequence; Bacterial Outer Membrane Proteins; Diethylstilbestrol; DNA Nucleotidyltransferases; Dose-Response Relationship, Drug; Estradiol; Estrogen Antagonists; Estrogens, Non-Steroidal; Fulvestrant; Hexestrol; HSP90 Heat-Shock Proteins; Humans; Ligands; Molecular Sequence Data; Nafoxidine; Piperidines; Raloxifene Hydrochloride; Receptors, Estrogen; Recombinant Fusion Proteins; Tamoxifen; Time Factors; Yeasts

1997
The anti-estrogen hydroxytamoxifen is a potent antagonist in a novel yeast system.
    Biological chemistry, 1999, Volume: 380, Issue:11

    Topics: Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Humans; Indoles; Nafoxidine; Piperidines; Polyunsaturated Alkamides; Receptors, Estrogen; Saccharomyces cerevisiae; Sulfones; Tamoxifen; Two-Hybrid System Techniques

1999